Table 2.
Use and timing of imaging
| Imaging modality | No of patients with at least one exam performed (%) |
Median time (days) after date of suspected IE (IQR) | |||
|---|---|---|---|---|---|
| Totala | NVE | PVE | P-value | ||
| Transthoracic echocardiography (TTE) | 136 (97.8) | 84 (98.8%) | 44 (97.8%) | >0.999 | 0 (0–2) |
| Transoesophageal echocardiography (TOE) | 113 (81.3) | 65 (76.5%) | 37 (82.2%) | 0.056 | 3 (1–6) |
| Multislice CT-scan (total) | 59 (42.4) | 32 (37.6%) | 25 (55.6%) | 0.064 | 5 (1–11) |
| Multislice CT-scan (cardiac) | 37 (26.6) | 20 (23.5%) | 16 (35.6%) | 0.155 | 7 (2–12) |
| MRI (total) | 31 (22.3) | 18 (21.2%) | 10 (22.2%) | 0.665 | 2 (−1–6) |
| FDG PET-CT scan | 63 (45.3) | 26 (30.6%) | 27 (60.0%) | <0.001 | 6 (3–10) |
Values expressed as median (interquartile range)
aCardiac-device related IE (CDRIE) cases are also included in the total group